“The widening of differential copays to incent the usage of both therapeutic and chemical equivalents is an effective method in driving utilization to generics and lowering costs, particularly in light of recent or anticipated generic releases that have been forecasted to represent approximately $35 billion in overall brand drug spend over the next year.”
— Allan Zimmerman, a director in the PricewaterhouseCoopers Human Resource Services practice, told AIS’s Drug Benefit News.
At Medicare is Simple, we look to educate and enable you to choose among Medicare plans to help find the policy that may best fit your needs. Get free quotes using our advanced quoting technology. HealthCare Reform is also a hot topic of interest to people of all ages, and we look to keep you updated on the issues relevant to learning more. Medicare Is Simple 800-442-4915
No comments:
Post a Comment